26
2018
-
04
Our company's technological transformation project was praised by Nantong leaders.
Our company's technological transformation project was praised by Nantong leaders.
On April 24, Nantong held a first quarter of industrial project observation activities. Lu Zhipeng, secretary of the Nantong Municipal CPC Committee, and Xu Huimin, deputy secretary of the Nantong Municipal CPC Committee and acting mayor, led a team to observe the construction of major projects. Qidong city leaders Wang Xiaobin, Wang Kangli, Gao Guangjun to participate in the activities.
Xu Zong of the company introduced the development of the company and the construction of technological transformation projects to the leaders of Nantong Municipal Committee.
The investment and construction of our company's technological transformation project is implemented in three phases. The first phase of the project is planned to have a total investment of 0.12 billion yuan. Construction will start in December 2016, with a new production workshop of 43000 square meters and 5 new Huaier particle production lines. It is planned to be completed and put into operation in August 2018. The second phase of the GMP workshop expansion project, with a planned total investment of 0.11 billion yuan, will start construction in April 2017, with a new construction area of 20000 square meters, and is expected to be completed and put into operation in December 2018. In 2019, it is planned to implement the third phase of technological transformation project, with a total investment of 0.15 billion yuan, an additional 35000 square meters of raw material workshop and 5 new raw material production lines. The company's technical transformation projects are all up to the post-partum, the annual production capacity is expected to reach 3 billion yuan. Huaier granule is a national first-class new drug, which is mainly used for liver cancer and other common tumors. In 2017, Huaier granule was included in the diagnosis and treatment standard of primary liver cancer by the national health and Family Planning Commission. It is the only drug with positive results proved by large sample clinical research. The market outlook is positive. Enterprises are confident and determined to achieve the goal of 10 billion enterprises within 10 years. Lu Zhipeng hopes that enterprises will speed up their construction, strengthen their confidence and become bigger and stronger, and achieve the goal of 10 billion yuan as soon as possible.
More news